StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.17−0.03 (-1.36%)

Close on Nov 16, 2026Market cap $138.23MP/E –Yield –

MacroGenics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for MacroGenics

MacroGenics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MacroGenics figures

See a number that looks wrong?